The immunoblot results confirmed that knockdown of EIF4G1 by RNAi significantly reduced the phosphorylation of NF‐κB p65 kinase from all the 3 NSCLC cell lines being tested (Fig. S2B). The gene discussed is EIF4G1; the disease is non-small cell lung carcinoma.